News & Events

2024 Annual ALS Patient Symposium

The ALS Patient Symposium is an annual event, offering patients, family members and health care providers an opportunity to learn about what’s new in ALS patient care and research. This …

Read more

Dr. Michael Benatar Honored for Innovative ALS Discoveries

University of Miami Miller School of Medicine neurologist Michael Benatar, M.D., Ph.D., was one of seven researchers who received the Sean M. Healey International Prize for Innovation in ALS at the 34th International Symposium on ALS/MND …

Read more

Marlins Triple Play 5K

Please join us for the 2nd Annual Marlins Triple Play 5K, presented by UHealth, on December 16, 2023! People of all ages are invited to round the bases on the …

Read more

Guiding Clinical Care for People at Risk for ALS and FTD

An international workshop co-led by University of Miami Miller School of Medicine neurologist Michael Benatar, M.D., Ph.D., laid the foundation for developing guidance for the clinical care of people at elevated genetic …

Read more

International Workshop Focuses on Defining Prodromal Phases of ALS, FTD

Michael Benatar, M.D., Ph.D., at the University of Miami organized and hosted the Second International Pre-Symptomatic ALS Workshop on February 27, 2023, which focused on defining the prodromal stages of …

Read more

New Grants Support Six Projects with ‘Ambitious Goal’ of Preventing ALS

Read the full update at the link below. View update

Read more

Dealing ALS a New Hand

Research reveals clues that may enable treatment even before symptoms show. Read the full article at the link below. View Article

Read more

Miller School Studies Pave the Way for the First Pre-Symptomatic ALS Trial for Individuals with SOD1 Genetic Mutation

For more than a decade, investigators at the University of Miami Miller School of Medicine have been studying the earliest signs of amyotrophic lateral sclerosis (ALS). Now, armed with biomarkers …

Read more

UM Researchers’ Validation of ALS Biomarker Could Accelerate Development of New Therapies

Researchers at the University of Miami Miller School of Medicine have validated a biomarker for amyotrophic lateral sclerosis (ALS) – a finding that could lead to faster and more efficient …

Read more

ALS Center investigators host first international Pre-Symptomatic ALS Workshop

The first Pre-Symptomatic ALS Workshop, organized and hosted by Dr. Michael Benatar (University of Miami), took place in Miami on January 27th, 2020. This Workshop brought together ~40 specialists in …

Read more

CReATe Consortium Aims for ALS Breakthroughs with NIH Renewal Grant

An international research consortium led by investigators at the University of Miami Miller School of Medicine has made significant progress in understanding amyotrophic lateral sclerosis (ALS) and related diseases since …

Read more

Phase III Trial Evaluating Arimoclomol for ALS Patients Reaches Full Enrollment

An international phase III clinical trial evaluating the drug Arimoclomol for the treatment of amyotrophic lateral sclerosis (ALS) has reached full enrollment, as reported by a University of Miami Miller …

Read more